Yoko Irie
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Cardiovascular Health and Disease Prevention
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
Papers in
-
- Cardiovascular Health and Disease Prevention 9
- Cardiovascular Function and Risk Factors 2
-
- Cerebrovascular and Carotid Artery Diseases 9
- Co-authors
- Iichiro Shimomura (13 shared papers)Naoto Katakami (13 shared papers)Hideaki Kaneto (10 shared papers)Mitsuyoshi Takahara (9 shared papers)Keisuke Kosugi (9 shared papers)Kenya Sakamoto (9 shared papers)Taka‐aki Matsuoka (6 shared papers)Yutaka Umayahara (6 shared papers)
- Journals
- Atherosclerosis (3 papers)Diabetes Research and Clinical Practice (3 papers)Journal of Atherosclerosis and Thrombosis (2 papers)Diabetes Care (2 papers)Diabetes Therapy (1 paper)
- Partner nations
- Japan
In The Last Decade
Yoko Irie
17 papers receiving 358 citations
Peers
Comparison fields: 5 of 61
- Clinical Biochemistry 81
- Cardiology and Cardiovascular Medicine 186
- Endocrinology, Diabetes and Metabolism 120
- Pulmonary and Respiratory Medicine 109
- Ophthalmology 21
Countries citing papers authored by Yoko Irie
This map shows the geographic impact of Yoko Irie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Irie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Irie more than expected).
Fields of papers citing papers by Yoko Irie
This network shows the impact of papers produced by Yoko Irie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Irie. The network helps show where Yoko Irie may publish in the future.
Co-authors
The 25 scholars most cited alongside Yoko Irie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 84 | |
| 2 | 2012 | 49 | |
| 3 | 2013 | 35 | |
| 4 | 2018 | 34 | |
| 5 | 2014 | 29 | |
| 6 | 2013 | 21 | |
| 7 | 2011 | 20 | |
| 8 | 2018 | 18 | |
| 9 | 2012 | 17 | |
| 10 | 2014 | 14 | |
| 11 | 2012 | 14 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2018 | 3 | |
| 16 | Improving Effects of SGLT2 Inhibitors on the Hepatic Function and FIB4 Index in Patients With Type 2 Diabetes | 2019 | 1 |
| 17 | 2015 | 1 |
About Yoko Irie
Yoko Irie is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology, having authored 17 papers that have together received 362 indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (9 papers), Cerebrovascular and Carotid Artery Diseases (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Diabetes Treatment and Management (2 papers), Cardiovascular Function and Risk Factors (2 papers), Diet, Metabolism, and Disease (1 paper), Health and Lifestyle Studies (1 paper) and Dietary Effects on Health (1 paper). The work is most often cited by research in Clinical Biochemistry (81 citations), Cardiology and Cardiovascular Medicine (186 citations), Endocrinology, Diabetes and Metabolism (120 citations), Pulmonary and Respiratory Medicine (109 citations) and Ophthalmology (21 citations). Yoko Irie has collaborated with scholars based in Japan. Frequent co-authors include Iichiro Shimomura, Naoto Katakami, Hideaki Kaneto, Mitsuyoshi Takahara, Keisuke Kosugi, Kenya Sakamoto, Taka‐aki Matsuoka, Yutaka Umayahara, Fumie Sakamoto and Tetsuyuki Yasuda. Their work appears in journals such as Atherosclerosis, Diabetes Research and Clinical Practice, Journal of Atherosclerosis and Thrombosis, Diabetes Care and Diabetes Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.